UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Management of perianal fistulas in Crohn's disease: an up-to-date review

World journal of gastroenterology : WJG, 2015-02, Vol.21 (5), p.1394-1403

2015

Volltextzugriff (PDF)

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver

International journal of molecular sciences, 2018-07, Vol.19 (8), p.2199

2018

Volltextzugriff (PDF)

Venous thromboembolism in patients with inflammatory bowel disease:Focus on prevention and treatment

World journal of gastroenterology : WJG, 2014-03, Vol.20 (12), p.3173-3179

2014

Volltextzugriff (PDF)

Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease

Journal of Crohn's and colitis, 2013-11, Vol.7 (10), p.769-779

2013

Volltextzugriff (PDF)

What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

World journal of gastrointestinal pharmacology and therapeutics, 2016-08, Vol.7 (3), p.387-396

2016

Volltextzugriff (PDF)

Treatment of Crohn's disease with colony-stimulating factors: An overview

Therapeutics and clinical risk management, 2008-10, Vol.4 (5), p.927-934

2008

Volltextzugriff (PDF)

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year

Digestive and liver disease, 2014-11, Vol.46 (11), p.974-979

2014

Volltextzugriff (PDF)

Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study

Journal of Crohn's and colitis, 2018-08, Vol.12 (9), p.1079-1088

2018

Volltextzugriff (PDF)

Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing

Inflammatory bowel diseases, 2015-05, Vol.21 (5), p.1204-1213

2015

Volltextzugriff (PDF)

SICUS and CEUS imaging in Crohn’s disease: an update

Journal of ultrasound, 2017-03, Vol.20 (1), p.1-9

2017

Volltextzugriff (PDF)

Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study

Journal of Crohn's and colitis, 2013-12, Vol.7 (12), p.e623-e629

2013

Volltextzugriff (PDF)

Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission

Inflammatory bowel diseases, 2013-04, Vol.19 (5), p.1065-1072

2013

Volltextzugriff (PDF)

Infliximab: A Review of Its Use in the Treatment of Inflammatory Bowel Disease

Clinical Medicine Insights: Therapeutics, 2011-01, Vol.2011 (3), p.CMT.S1978

2011

Volltextzugriff (PDF)

Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study

Digestive and liver disease, 2024-01, Vol.56 (1), p.77-82

2024

Volltextzugriff (PDF)

Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases

Expert opinion on biological therapy, 2015-08, Vol.15 (8), p.1107-1117

2015

Volltextzugriff (PDF)

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents

Journal of Crohn's and colitis, 2013-03, Vol.7 (2), p.113-119

2013

Volltextzugriff (PDF)

Sa1978 Infliximab Trough Levels After Dose Optimization for Loss of Response Predict Outcome at One Year

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S422-S422

2016

Volltextzugriff (PDF)

Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study

Expert opinion on pharmacotherapy, 2023-09, Vol.ahead-of-print (ahead-of-print), p.1-8

2023

Volltextzugriff (PDF)

Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study

Expert opinion on biological therapy, 2024, Vol.24 (1-2), p.101-109

2024

Volltextzugriff (PDF)

Tu1313 Infliximab Is More Effective Than Azathioprine in the Long-Term Prevention of Postoperative Recurrence of Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-856-S-856

2015

Volltextzugriff (PDF)

Tu1315 Loss of Response in IBD Patients on Infliximab Treatment: Assay of Infliximab Trough Levels and Total Antibodies to Infliximab

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-857-S-857

2015

Volltextzugriff (PDF)

Management of perianal fistulas in Crohn’s disease:An upto-date review

世界胃肠病学杂志：英文版, 2015 (5), p.1394-1403

Manuela Marzo Carla Felice Daniela Pugliese Gianluca Andrisani Giammarco Mocci Alessandro Armuzzi Luisa Guidi

2015

Volltextzugriff (PDF)

Ileal Crohn's disease: CEUS determination of activity

Abdominal imaging, 2012-06, Vol.37 (3), p.359

2012

Volltextzugriff (PDF)

342 Retreatment With Infliximab in Inflammatory Bowel Disease: Tolerability and Effectiveness of Different Re-Induction Regimens

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-78-S-79

2014

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(34)
Humans
(26)
Gastroenterology And Hepatology
(24)
Gastroenterology & Hepatology
(16)
Female
(13)
Male
(13)
Adult
(10)
Inflammatory Bowel Disease
(10)
Physics
(10)
Applied And Technical Physics
(8)
Atomic
(8)
Complex Systems
(8)
Condensed Matter Physics
(8)
Inflammatory Bowel Diseases - Drug Therapy
(8)
Infliximab
(8)
Mathematical And Computational Physics
(8)
Middle Aged
(8)
Molecular
(8)
Optical And Plasma Physics
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of perianal fistulas in Crohn's disease: an up-to-date review

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver

Venous thromboembolism in patients with inflammatory bowel disease:Focus on prevention and treatment

Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease

What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

Treatment of Crohn's disease with colony-stimulating factors: An overview

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year

Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study

Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing

SICUS and CEUS imaging in Crohn’s disease: an update

Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study

Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission

Infliximab: A Review of Its Use in the Treatment of Inflammatory Bowel Disease

Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study

Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents

Sa1978 Infliximab Trough Levels After Dose Optimization for Loss of Response Predict Outcome at One Year

Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study

Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study

Tu1313 Infliximab Is More Effective Than Azathioprine in the Long-Term Prevention of Postoperative Recurrence of Crohn's Disease

Tu1315 Loss of Response in IBD Patients on Infliximab Treatment: Assay of Infliximab Trough Levels and Total Antibodies to Infliximab

Management of perianal fistulas in Crohn’s disease:An upto-date review

H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy

Ileal Crohn's disease: CEUS determination of activity

342 Retreatment With Infliximab in Inflammatory Bowel Disease: Tolerability and Effectiveness of Different Re-Induction Regimens

Suchergebnisse filtern